Jane Street Group, LLC Bio Techne Corp Transaction History

Jane Street Group, LLC

$616 Billion
Q3 2025

A detailed history of Jane Street Group, LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Jane Street Group, LLC holds 20,300 shares of TECH stock, worth $1.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,300

Previous 14,269 42.27%

Holding current value

$1.21 Million

Previous $734,000 53.81%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$46.66 - $58.38 $665,791 - $833,024	14,269 New	14,269 $734,000
Q4 2024 Feb 14, 2025	SELL	$66.37 - $78.17 $87,608 - $103,184	-1,320 Reduced 9.1%	13,190 $950,000
Q3 2024 Nov 14, 2024	SELL	$70.96 - $82.35 $6.03 Million - $7 Million	-84,988 Reduced 85.42%	14,510 $1.16 Million
Q2 2024 Aug 14, 2024	BUY	$62.12 - $84.15 $3.08 Million - $4.18 Million	49,659 Added 99.64%	99,498 $7.13 Million
Q1 2024 May 15, 2024	SELL	$65.98 - $77.09 $1.09 Million - $1.28 Million	-16,547 Reduced 24.93%	49,839 $3.51 Million

Q4 2023 Feb 14, 2024	BUY	$52.83 - $78.22 $1.16 Million - $1.72 Million	22,011 Added 49.6%	66,386 $5.12 Million
Q3 2023 Nov 14, 2023	BUY	$67.52 - $89.42 $2.05 Million - $2.71 Million	30,294 Added 215.14%	44,375 $3.02 Million
Q2 2023 Aug 14, 2023	SELL	$73.76 - $85.98 $19,915 - $23,214	-270 Reduced 1.88%	14,081 $1.15 Million
Q1 2023 May 15, 2023	BUY	$71.62 - $86.62 $279,246 - $337,731	3,899 Added 37.3%	14,351 $1.06 Million
Q4 2022 Feb 14, 2023	SELL	$80.67 - $352.29 $264,274 - $1.15 Million	-3,276 Reduced 23.86%	10,452 $866,000
Q3 2022 Nov 14, 2022	BUY	$282.54 - $391.85 $1.11 Million - $1.53 Million	3,917 Added 39.92%	13,728 $3.9 Million
Q2 2022 Aug 16, 2022	BUY	$322.67 - $449.65 $2.55 Million - $3.56 Million	7,911 Added 416.37%	9,811 $3.4 Million
Q1 2022 May 17, 2022	BUY	$353.85 - $487.79 $165,247 - $227,797	467 Added 32.59%	1,900 $823,000
Q4 2021 Feb 15, 2022	BUY	$456.15 - $525.06 $120,879 - $139,140	265 Added 22.69%	1,433 $741,000
Q3 2021 Nov 16, 2021	SELL	$444.87 - $538.88 $9.52 Million - $11.5 Million	-21,405 Reduced 94.83%	1,168 $566,000
Q2 2021 Aug 16, 2021	BUY	$387.35 - $450.26 $7.57 Million - $8.8 Million	19,535 Added 643.02%	22,573 $10.2 Million
Q1 2021 May 18, 2021	BUY	$314.62 - $411.0 $41,529 - $54,252	132 Added 4.54%	3,038 $1.16 Million
Q4 2020 Feb 17, 2021	BUY	$246.9 - $321.87 $223,938 - $291,936	907 Added 45.37%	2,906 $923,000
Q3 2020 Nov 17, 2020	SELL	$232.22 - $282.96 $314,890 - $383,693	-1,356 Reduced 40.42%	1,999 $495,000
Q2 2020 Aug 17, 2020	BUY	$185.43 - $279.56 $622,117 - $937,923	3,355 New	3,355 $886,000
Q1 2020 May 15, 2020	SELL	$161.17 - $221.51 $272,377 - $374,351	-1,690 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$189.68 - $222.09 $320,559 - $375,332	1,690 New	1,690 $371,000
Q3 2019 Nov 14, 2019	SELL	$183.56 - $216.72 $571,789 - $675,082	-3,115 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$188.72 - $215.43 $312,142 - $356,321	1,654 Added 113.21%	3,115 $649,000
Q1 2019 May 16, 2019	BUY	$136.09 - $200.44 $198,827 - $292,842	1,461 New	1,461 $290,000
Q4 2018 Feb 15, 2019	SELL	$132.75 - $203.8 $1.73 Million - $2.66 Million	-13,062 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$147.44 - $204.11 $1.93 Million - $2.67 Million	13,062 New	13,062 $2.67 Million
Q1 2018 May 15, 2018	SELL	$131.46 - $151.04 $396,483 - $455,536	-3,016 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$121.17 - $134.75 $54,405 - $60,502	449 Added 17.49%	3,016 $391,000
Q3 2017 Nov 14, 2017	BUY	$113.59 - $123.78 $291,585 - $317,743	2,567	2,567 $310,000

Others Institutions Holding TECH

# of Institutions

653

Shares Held

162M

Call Options Held

514K

Put Options Held

347K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.33B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Bio Techne Corp Transaction History